TruaceTracing the truth around AIMonday, September 14, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,402 results
Show filters and sorting

AI gains · 778

81
GainScience· Stable· Evidence: High (5 sources)

In the past decade, the global industry and research attentions on intelligent skin-like electronics have boosted their applications in diverse fields including human healthcare, Internet of Things, human-machine interfaces, artificial intelligence and soft robotics.

In the past decade, the global industry and research attentions on intelligent skin-like electronics have boosted their applications in diverse fields including human healthcare, Internet of Things, human-machine interfaces, artificial intelligence and soft robotics. Among them, flexible humidity sensors play a vital role in noncontact measurements relying on the unique property of rapid response to humidity change.

Impact 30%49
Evidence 25%100
Scale 20%85
Confidence 15%100
Recency 10%88

Updated Jul 12, 2026 · TRV-2026-0062

79
GainHealth· Newly added· Evidence: Moderate (1 source)

Interpretable random survival forest model predicted all-cause mortality in adults with unrepaired PAH-CHD and stratified survival in both Eisenmenger and non-Eisenmenger subgroups where the ESC model did not.

Researchers developed and internally validated an interpretable machine learning risk model for adults with unrepaired pulmonary arterial hypertension associated with congenital heart disease using data from 601 patients in a Chinese national prospective registry followed for a median 76 months. A random survival forest achieved a bootstrapping C-index of 0.773, and SHAP analysis highlighted predictors such as hemoglobin, BMI, systolic blood pressure, and diastolic pulmonary artery pressure to build new risk strata.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%100

Updated Sep 14, 2026 · TRV-2026-1083

79
GainHealth· Newly added· Evidence: Moderate (1 source)

AI systems are being developed to fuse facial expressions, voice, and physiological signals to objectively quantify pain and to automatically segment spine, nerves, and needle tips to improve identification accuracy.

A September 2026 review in Journal of Translational Medicine surveyed AI research in pain medicine across three areas: objective pain assessment by fusing facial expressions, voice and physiological signals, automated segmentation of spine, nerves and needle tips from medical images, and AI support for classification, treatment decisions and prognosis in conditions from osteoarthritis to cancer pain.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%100

Updated Sep 14, 2026 · TRV-2026-1080

79
GainHealth· Newly added· Evidence: Moderate (1 source)

Systematic review finds AI and deep learning models achieve high accuracy on cytology and histopathology images and offer gains in consistency, speed, cost-effectiveness, and reduced pathologist workload in breast cancer screening and diagnosis.

A systematic review published September 12, 2026 reviewed AI and machine learning techniques for breast cancer screening, diagnosis, classification and tumor marker scoring. It examined advanced deep learning models including ANNs, SVMs, CNNs and faster R-CNN applied to cytology, histopathology and combined imaging-pathology data.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%100

Updated Sep 14, 2026 · TRV-2026-1079

AI problems · 624

78
ProblemHealth· Newly added· Evidence: Moderate (1 source)

Results Yet, challenges persist, including algorithmic bias, data inequity and variable regulatory standards across regions.

Background Artificial intelligence (AI) is transforming global health care through innovations in deep learning, generative models and agentic AI systems. Traditional reductionist approaches to complex pathophysiological pathways fail to capture the true complexity of disease, motivating the adoption of network medicine (NM), which models biological systems as dynamic, interconnected networks.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%98

Updated Sep 3, 2026 · TRV-2026-0972

78
ProblemHealth· Newly added· Evidence: Moderate (1 source)

Implementation of AI for cardiovascular prevention remains limited by insufficient prospective evidence and randomized trials, lack of validation in heterogeneous populations, limited model interpretability, and inadequate digital and regulatory infrastructures, leaving a gap between guideline recommendations and real‑

This peer-reviewed review examines AI, including machine learning and deep learning, for cardiovascular prevention in Italy and globally, where cardiovascular diseases remain the leading cause of mortality and morbidity. It surveys evidence that AI can deliver more precise, dynamic and personalized risk stratification than traditional scores and support early detection of subclinical disease via AI-enabled electrocardiography and opportunistic imaging.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%97

Updated Sep 1, 2026 · TRV-2026-0955

78
ProblemHealth· Newly added· Evidence: Moderate (1 source)

AI application in xenotransplantation is limited by lack of clinical data, species-specific differences, and missing standardized definitions and ground truth datasets for xenograft injury.

On September 1, 2026, a peer-reviewed roadmap in Xenotransplantation outlined how artificial intelligence could be integrated into early clinical xenotransplantation to address organ shortage. It prioritizes digital pathology, machine perfusion monitoring, multimodal graft injury detection, and xenozoonotic infection surveillance, emphasizing clinician-supervised, auditable systems combined with gene-edited donors.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%97

Updated Sep 1, 2026 · TRV-2026-0953

78
ProblemHealth· Stable· Evidence: Moderate (1 source)

Conventional ultrasound imaging's profound reliance on operator expertise restricts reproducibility and global accessibility.

This comprehensive review traces ultrasound from operator-dependent manual imaging to robotic ultrasound systems developed over the past two decades, including teleoperated telesonography over 5G and increasingly autonomous platforms using force control and path planning.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%96

Updated Aug 26, 2026 · TRV-2026-0898

Recomputed live from the record · Sep 14, 2026, 7:28 AM